Literature DB >> 2911656

Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings.

E E de Lange1, R E Fechner, H J Wanebo.   

Abstract

Eleven patients who underwent abdominoperineal resection for rectosigmoid carcinoma were examined with magnetic resonance (MR) imaging for suspected recurrent tumor in the presacral space. There were 12 suspected masses in the 11 patients. Ten lesions were malignant, and in two lesions only nonneoplastic inflammatory tissue was found. The signal intensity (SI) of each lesion relative to that of muscle was determined visually and correlated with the histologic findings at surgery or biopsy. The SIs of malignant and benign lesions were indistinguishable. All lesions showed areas of high SI that correlated with carcinoma and tumor necrosis or with non-neoplastic inflammation and edema. Areas of low SI corresponded to reactive fibrous tissue (desmoplastic reaction) with small islands of tumor or to nonneoplastic fibrosis. MR imaging can be useful in determining the extent of suspected tumors, but SIs on T2-weighted images do not permit histologic diagnosis. In particular, distinction of benign from malignant tissue is difficult in tumors with a desmoplastic reaction.

Entities:  

Mesh:

Year:  1989        PMID: 2911656     DOI: 10.1148/radiology.170.2.2911656

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Local recurrence of rectosigmoid cancer: what about the choice of MRI for diagnosis?

Authors:  L Balzarini; E Ceglia; G D'Ippolito; R Petrillo; J D Tess; R Musumeci
Journal:  Gastrointest Radiol       Date:  1990

Review 2.  Locally recurrent rectal cancer: surgical strategy.

Authors:  J P de Azevedo; R R Dozois; L L Gunderson
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

3.  The role of FDG-PET/CT in the detection of recurrent colorectal cancer.

Authors:  Jana Votrubova; Otakar Belohlavek; Monika Jaruskova; Martin Oliverius; Radka Lohynska; Kristina Trskova; Eva Sedlackova; Ludmila Lipska; Vladimira Stahalova
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-25       Impact factor: 9.236

4.  Superimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence.

Authors:  J C Liehn; A Loboguerrero; C Pérault; L Demange
Journal:  Eur J Nucl Med       Date:  1992

5.  Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity.

Authors:  K Ito; T Kato; T Ohta; M Tadokoro; T Yamada; M Ikeda; M Nishino; T Ishigaki; S Gambhir
Journal:  Eur J Nucl Med       Date:  1996-10

6.  Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.

Authors:  A Chetanneau; R P Baum; P A Lehur; J C Liehn; A C Perkins; R Bares; P Bourguet; J Y Herry; J C Saccavini; J F Chatal
Journal:  Eur J Nucl Med       Date:  1990

7.  FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences.

Authors:  Verena Plodeck; Nuh N Rahbari; Juergen Weitz; Christoph G Radosa; Michael Laniado; Ralf-Thorsten Hoffmann; Klaus Zöphel; Bettina Beuthien-Baumann; Joerg Kotzerke; Joerg van den Hoff; Ivan Platzek
Journal:  Eur Radiol       Date:  2018-07-06       Impact factor: 5.315

8.  Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.

Authors:  Liviu V Titu; Anthony A Nicholson; John E Hartley; David J Breen; John R T Monson
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

9.  Immunoscintigraphy of colorectal carcinoma utilizing 111In-labeled monoclonal antibody conjugate CYT-103.

Authors:  C E Neal; T L Swan; M R Baker; R L Ellis; J G Katterhagen
Journal:  Gastrointest Radiol       Date:  1991

10.  Pelvic resection of recurrent rectal cancer.

Authors:  H J Wanebo; R J Koness; M P Vezeridis; S I Cohen; D E Wrobleski
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.